Evidence map›Paper›PMID 24675033›Full record

ArticleBrain, behavior, and immunity2014

Innate immune factors modulate ethanol interaction with GABAergic transmission in mouse central amygdala.

Michal Bajo, Samuel G Madamba, Marisa Roberto, Yuri A Blednov, Vasudeva N Sagi, Edward Roberts, Kenner C Rice, R Adron Harris, George R Siggins

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Astrocyte Reactivity by Alcohol Dependence in the Central Amygdala.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Synaptic effects of IL-1β and CRF in the central amygdala after protracted alcohol abstinence in male rhesus macaques.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Neuroimmune signaling in alcohol use disorder.Pharmacology, biochemistry, and behavior · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michal BajoCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 N. Torrey Pines, La Jolla, CA 92037, USA. Electronic address: mbajo@scripps.edu.
Samuel G MadambaCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 N. Torrey Pines, La Jolla, CA 92037, USA.
Marisa RobertoCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 N. Torrey Pines, La Jolla, CA 92037, USA.
Yuri A BlednovWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
Vasudeva N SagiDepartment of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines, La Jolla, CA 92037, USA.
Edward RobertsDepartment of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines, La Jolla, CA 92037, USA.
Kenner C RiceChemical Biology Research Branch, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, Rockville, MD 20852, USA.
R Adron HarrisWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
George R SigginsDepartment of Molecular and Cellular Neuroscience, The Scripps Research Institute, 10550 N. Torrey Pines, La Jolla, CA 92037, USA. Electronic address: geobob@scripps.edu.
Scripps Research Institute · USThe University of Texas at Austin · USNational Institute on Drug Abuse · US

Funding

Integrative Neuroscience Initiative on Alcoholism - West - SupplementU01AA013517 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2001 to 2014
$12.7M
Electrophysiology of alcohol in extended amygdelaU01AA013498 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 2001 to 2026
$12.6M
INIA: ANIMAL COREU01AA013520 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI YURI A BLEDNOV, ROBERT O. MESSING · 2001 to 2026
$9.5M
Medicinal Chemistry in the Study of Alcohol AbuseZIADA000531 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2016
$1.1M
Intramural NIH HHSNIAAA NIH HHS U01 AA013498NIAAA NIH HHS U01 AA013517NIAAA NIH HHS U01-AA013517NIAAA NIH HHS U01 AA013520NIAAA NIH HHS U01-AA013520
6 · The paper itself

Abstract

Excessive ethanol drinking in rodent models may involve activation of the innate immune system, especially toll-like receptor 4 (TLR4) signaling pathways. We used intracellular recording of evoked GABAergic inhibitory postsynaptic potentials (eIPSPs) in central amygdala (CeA) neurons to examine the role of TLR4 activation by lipopolysaccharide (LPS) and deletion of its adapter protein CD14 in acute ethanol effects on the GABAergic system. Ethanol (44, 66 or 100mM) and LPS (25 and 50μg/ml) both augmented eIPSPs in CeA of wild type (WT) mice. Ethanol (44mM) decreased paired-pulse facilitation (PPF), suggesting a presynaptic mechanism of action. Acute LPS (25μg/ml) had no effect on PPF and significantly increased the mean miniature IPSC amplitude, indicating a postsynaptic mechanism of action. Acute LPS pre-treatment potentiated ethanol (44mM) effects on eIPSPs in WT mice and restored ethanol's augmenting effects on the eIPSP amplitude in CD14 knockout (CD14 KO) mice. Both the LPS and ethanol (44-66mM) augmentation of eIPSPs was diminished significantly in most CeA neurons of CD14 KO mice; however, ethanol at the highest concentration tested (100mM) still increased eIPSP amplitudes. By contrast, ethanol pre-treatment occluded LPS augmentation of eIPSPs in WT mice and had no significant effect in CD14 KO mice. Furthermore, (+)-naloxone, a TLR4-MD-2 complex inhibitor, blocked LPS effects on eIPSPs in WT mice and delayed the ethanol-induced potentiation of GABAergic transmission. In CeA neurons of CD14 KO mice, (+)-naloxone alone diminished eIPSPs, and subsequent co-application of 100mM ethanol restored the eIPSPs to baseline levels. In summary, our results indicate that TLR4 and CD14 signaling play an important role in the acute ethanol effects on GABAergic transmission in the CeA and support the idea that CD14 and TLR4 may be therapeutic targets for treatment of alcohol abuse.

Indexed as

Immunity, InnateAnimalsCentral Amygdaloid NucleusEthanolImmunologic FactorsInhibitory Postsynaptic PotentialsLipopolysaccharide ReceptorsLipopolysaccharidesMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsReceptors, GABA-ASynaptic TransmissionToll-Like Receptor 4EthanolImmunologic FactorsLipopolysaccharide ReceptorsLipopolysaccharidesReceptors, GABA-AToll-Like Receptor 4AlcoholDrug abuseExtended amygdalaInflammationLPSNeuroimmuneToll-like receptor

Identifiers

PMID24675033
PMCPMC4126651
OpenAlexW2090785150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.